title: L-Asparagine depletion levels and L-asparaginase activity in plasma of children with acute lymphoblastic leukemia under asparaginase treatment.
abstract: OBJECTIVE
  To determine the minimum levels of L-asparaginase (ASNase) activity necessary to maintain L-asparagine (Asn) depletion under ASNase treatment in acute lymphoblastic leukemia (ALL).
  
  
  METHODS
  We measured ASNase activity using an enzyme coupling method with a limit of detection of 2 U/l and examined the relationship between ASNase activity and Asn levels in blood samples from 14 children with ALL.
  
  
  RESULTS
  In all but one patient showing high ASNase antibody titers, minimum ASNase activity to maintain Asn depletion levels below the limit of detection (40 ng/ml) ranged from 6 to 180 U/l with a median value of 16 U/l. In 11 patients, the enzyme activity corresponding to minimum detectable Asn levels ranged from 2 to 32 U/l with a median value of 6.5 U/l. Patients with an ASNase activity of 2 U/l or an undetectable activity (<2 U/l) had nearly normal Asn levels: 4140+/-1161 ng/ml at 2 U/l and 7235+/-3107 ng/ml at <2 U/l (mean+/-SD). Statistical analysis showed that ASNase activity in the range of 2-32 U/l was inversely correlated with Asn levels ( r=-0.803, P=0.001).
  
  
  CONCLUSIONS
  These results show that Asn levels are strongly correlated with plasma ASNase activity even at low enzyme activities (<50 U/l) and that this sensitive ASNase assay can be used to estimate plasma Asn depletion levels.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Aichi Medical University, 480-1195 Aichi, Japan. tsuru@aichi-med-u.ac.jp
authors.forename: Masahito
authors.initials: M
authors.lastname: Tsurusawa
authors.forename: Motoaki
authors.initials: M
authors.lastname: Chin
authors.forename: Asayuki
authors.initials: A
authors.lastname: Iwai
authors.forename: Keiko
authors.initials: K
authors.lastname: Nomura
authors.forename: Hideaki
authors.initials: H
authors.lastname: Maeba
authors.forename: Takashi
authors.initials: T
authors.lastname: Taga
authors.forename: Takeshi
authors.initials: T
authors.lastname: Higa
authors.forename: Tomoko
authors.initials: T
authors.lastname: Kuno
authors.forename: Toshinori
authors.initials: T
authors.lastname: Hori
authors.forename: Akiko
authors.initials: A
authors.lastname: Muto
authors.forename: Miyo
authors.initials: M
authors.lastname: Yamagata
mesh_terms: D000970:Antineoplastic Agents / Q000097:blood / Q000627:therapeutic use*; D001215:Asparaginase / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D001216:Asparagine / Q000097:blood*; D002648:Child; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D001216:Asparagine; D001215:Asparaginase